methylselenic acid has been researched along with selenomethionine in 16 studies
| Studies (methylselenic acid) | Trials (methylselenic acid) | Recent Studies (post-2010) (methylselenic acid) | Studies (selenomethionine) | Trials (selenomethionine) | Recent Studies (post-2010) (selenomethionine) |
|---|---|---|---|---|---|
| 144 | 1 | 68 | 1,797 | 82 | 613 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Reid, TW; Shriver, BJ; Spallholz, JE | 1 |
| Jiang, C; Lü, J; Wang, Z | 1 |
| Cho, SD; Dong, Y; Ip, C; Jiang, C; Kang, KS; Lee, YS; Lü, J; Malewicz, B; Young, CY | 1 |
| Brooks, JD; Zhao, H | 1 |
| Fischer, JL; Mihelc, EM; Pollok, KE; Smith, ML | 1 |
| Combs, GF; Hu, H; Lee, HJ; Li, GX; Liao, JD; Lü, J; Wang, Z; Watts, JC | 1 |
| Franklin, MR; Moos, PJ; Poerschke, RL | 1 |
| Kumar, MS; Pollok, KE; Smith, ML | 1 |
| Anderson, LB; Lü, J; Wang, L; Witthuhn, B; Xu, Y; Zhang, J | 1 |
| Anderson, LB; Li, G; Lü, J; Wang, L; Witthuhn, B; Xu, Y; Zhang, J | 1 |
| DeMars, LC; Yan, L | 1 |
| Chen, YC; Das, A; Mastro, AM; Prabhu, KS | 1 |
| Arakawa, T; Nakamuro, K; Ogino, H; Okuno, T; Sakazaki, F; Shimizu, R; Ueno, H | 1 |
| Han, F; Huang, Z; Liu, Y; Lu, J; Sun, L; Wang, Q; Yang, Y; Zhang, H | 1 |
| Goltyaev, MV; Mal'tseva, VN; Turovsky, EA; Varlamova, EG | 1 |
| Bosland, MC; Deng, Y; Lü, J; Schlicht, MJ | 1 |
1 review(s) available for methylselenic acid and selenomethionine
| Article | Year |
|---|---|
Immunomodulatory and Anti-Inflammatory Properties of Selenium-Containing Agents: Their Role in the Regulation of Defense Mechanisms against COVID-19.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; COVID-19 Drug Treatment; Humans; Immune System; Immunomodulating Agents; Organoselenium Compounds; Selenium Compounds; Selenocysteine; Selenomethionine; Sodium Selenite | 2022 |
1 trial(s) available for methylselenic acid and selenomethionine
| Article | Year |
|---|---|
Effect of Dietary Methylseleninic Acid and Se-Methylselenocysteine on Carcinogen-Induced, Androgen-Promoted Prostate Carcinogenesis in Rats.
Topics: Androgens; Animals; Antioxidants; Carcinogenesis; Carcinogens; Diet; Disease Models, Animal; Humans; Male; Mice; Organoselenium Compounds; Prostate; Prostatic Neoplasms; Rats; Selenium; Selenocysteine; Selenomethionine | 2022 |
14 other study(ies) available for methylselenic acid and selenomethionine
| Article | Year |
|---|---|
Dimethyldiselenide and methylseleninic acid generate superoxide in an in vitro chemiluminescence assay in the presence of glutathione: implications for the anticarcinogenic activity of L-selenomethionine and L-Se-methylselenocysteine.
Topics: Anticarcinogenic Agents; Cysteine; Glutathione; Glutathione Peroxidase; Kinetics; Luminescent Measurements; Organoselenium Compounds; Selenocysteine; Selenomethionine; Superoxide Dismutase; Superoxides | 2001 |
Induction of caspase-mediated apoptosis and cell-cycle G1 arrest by selenium metabolite methylselenol.
Topics: Apoptosis; Carbon-Sulfur Lyases; Caspases; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; G1 Phase; Humans; Methanol; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Organoselenium Compounds; Phosphorylation; Phosphoserine; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; S Phase; Selenium; Selenomethionine | 2002 |
Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription.
Topics: Androgens; Cell Death; Cell Line, Tumor; Humans; Male; Organoselenium Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Processing, Post-Translational; Receptors, Androgen; RNA, Messenger; Selenomethionine; Sodium Selenite; Time Factors; Transcription, Genetic | 2004 |
Selenomethionine induced transcriptional programs in human prostate cancer cells.
Topics: Humans; Male; Organoselenium Compounds; Prostatic Neoplasms; Selenomethionine; Transcription, Genetic; Tumor Cells, Cultured | 2007 |
Chemotherapeutic selectivity conferred by selenium: a role for p53-dependent DNA repair.
Topics: Animals; Cell Survival; DNA; DNA Repair; Fibroblasts; Genome; Humans; Mice; Organ Specificity; Organoplatinum Compounds; Organoselenium Compounds; Selenomethionine; Tumor Suppressor Protein p53; Ultraviolet Rays | 2007 |
Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Comet Assay; DNA Damage; Humans; Lymphocytes; Male; Mice; Mice, Nude; Neoplasm Transplantation; Organoselenium Compounds; Prostatic Neoplasms; Selenomethionine; Transplantation, Heterologous | 2008 |
Modulation of redox status in human lung cell lines by organoselenocompounds: selenazolidines, selenomethionine, and methylseleninic acid.
Topics: Cell Line, Transformed; Cell Line, Tumor; Cell Survival; Endoplasmic Reticulum; Humans; Lung Neoplasms; Organoselenium Compounds; Oxidation-Reduction; Oxidative Stress; Selenomethionine; Sulfhydryl Compounds | 2008 |
Selenomethionine or methylseleninic acid inhibits mutagenesis of a reporter gene in mouse bone marrow.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Carboplatin; DNA-Binding Proteins; Genes, Reporter; Maximum Tolerated Dose; Methionine; Mice; Mice, Knockout; Mutagenesis; Organoselenium Compounds; Selenomethionine | 2010 |
Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model.
Topics: Adenocarcinoma; Animals; Biomarkers, Pharmacological; Biomarkers, Tumor; Cysteine; Disease Models, Animal; Male; Metabolome; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Biological; Organoselenium Compounds; Prostatic Neoplasms; Proteomics; Selenium Compounds; Selenocysteine; Selenomethionine | 2010 |
Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds.
Topics: Animals; Anticarcinogenic Agents; Cysteine; Gene Expression Profiling; Gene Expression Regulation; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Organoselenium Compounds; Prostate; Prostatic Neoplasms; Protein Biosynthesis; Proteomics; RNA, Messenger; Selenium Compounds; Selenocysteine; Selenomethionine; Sodium Selenite; Xenograft Model Antitumor Assays | 2011 |
Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice.
Topics: Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Dietary Supplements; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Organoselenium Compounds; Selenomethionine; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A | 2012 |
Dietary selenium supplementation modifies breast tumor growth and metastasis.
Topics: Animals; Blotting, Western; Bone Neoplasms; Dietary Supplements; Female; Flow Cytometry; Interferon-gamma; Interleukin-2; Interleukin-6; Kidney Neoplasms; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Organoselenium Compounds; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selenomethionine; Sodium Selenite; Tumor Cells, Cultured | 2013 |
Effects of administering sodium selenite, methylseleninic acid, and seleno-L-methionine on glucose tolerance in a streptozotocin/nicotinamide-induced diabetic mouse model.
Topics: Animals; Biological Availability; Blood Glucose; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Hypoglycemic Agents; Liver; Male; Mice, Inbred ICR; Niacinamide; Organoselenium Compounds; Pancreas; Selenomethionine; Sodium Selenite; Streptozocin | 2014 |
[Effects of selenium compounds on proliferation, migration and adhesion of HeLa cells].
Topics: Anticarcinogenic Agents; Cell Movement; HeLa Cells; Humans; Organoselenium Compounds; Selenium; Selenium Compounds; Selenocysteine; Selenomethionine | 2015 |